NEOGEN CHEMICALS LTD.
NSE : NEOGENBSE : 542665ISIN
CODE : INE136S01016Industry : ChemicalsHouse
: Private
BSE1455.653.3 (+0.23 % )
PREV CLOSE (Rs.) 1452.35
OPEN PRICE (Rs.) 1467.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 196
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE1458.35 7 (+0.48 % )
PREV CLOSE(Rs.) 1451.35
OPEN PRICE (Rs.) 1466.10
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 2243
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Company News
| Date | Heading | Details |
|---|---|---|
| 02-May-2024 | Neogen Chemicals informs about earnings presentation | <p style="text-align: justify;">Neogen Chemicals has informed that it enclosed the Earnings Presentation on the audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2024. The audited Financial Results for the quarter and year ended March 31, 2024, and the Earnings Presentation are also being uploaded on the Company's website at https://neogenchem.com/financial-performance/.</p><div>The above information is a part of company's filings submitted to BSE.</div> |
| 02-May-2024 | Neogen Chemicals informs about press release | <p style="text-align: justify;">Neogen Chemicals has informed that it enclosed the Press Release on the audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2024. The Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2024 and the Press Release are also being uploaded on the Company's website at https://neogenchem.com/financial-performance/.</p><div>The above information is a part of company's filings submitted to BSE.</div> |
| 02-May-2024 | Allotment of Debentures | Inter alia, approved:- 1. Recommended a final dividend of Rs. 2.00 per Equity Share for the Financial Year 2023-24, subject to approval of shareholders at the ensuing Annual General Meeting of the Company 2. Pledge of Equity shares of WOS- NIL held by Neogen Chemicals Limited against the credit facilities to be availed by Neogen Ionics Limited. 3. In principle approval for subscription of upto 50,00,00,000 Compulsorily Convertible Debentures (?CCDs?) with coupon rate of 0.01% p.a. of a face value of Rs. 10 each amounting to Rs. 500,00,00,000 (Rupees Five Hundred Crores only) to be issued, offered and allotted on a rights basis by its WOS-NIL. 4. Subscription of upto 49,00,000 equity shares of a face value Rs. 10 each amounting to Rs. 4,90,00,000 (Rupees Four Crores Ninety Lakhs only) to be issued, offered and allotted on rights basis of its WOS- NIL. 5. The draft Scheme of Amalgamation of Buli Chemicals India Private Limited - wholly owned subsidiary ("Transferor Company?) with Neogen Chemical Limited- the holding company (?Transferee Company?) and their respective shareholders ("Scheme"), based on the recommendation of the Audit Committee, under section 230 to 232 and other applicable provisions of the Companies Act, 2013 and rules framed thereunder. The Scheme inter alia provides for the amalgamation of the Transferor Company with the Transferee Company. The Transferor Company is the wholly owned subsidiary of the Transferee Company. The Scheme is subject to necessary statutory and regulatory approvals under the applicable laws, including approval of the jurisdictional Hon?ble National Company Law Tribunal. |
| 02-May-2024 | Amalgamation | Inter alia, approved:- 1. Recommended a final dividend of Rs. 2.00 per Equity Share for the Financial Year 2023-24, subject to approval of shareholders at the ensuing Annual General Meeting of the Company 2. Pledge of Equity shares of WOS- NIL held by Neogen Chemicals Limited against the credit facilities to be availed by Neogen Ionics Limited. 3. In principle approval for subscription of upto 50,00,00,000 Compulsorily Convertible Debentures (?CCDs?) with coupon rate of 0.01% p.a. of a face value of Rs. 10 each amounting to Rs. 500,00,00,000 (Rupees Five Hundred Crores only) to be issued, offered and allotted on a rights basis by its WOS-NIL. 4. Subscription of upto 49,00,000 equity shares of a face value Rs. 10 each amounting to Rs. 4,90,00,000 (Rupees Four Crores Ninety Lakhs only) to be issued, offered and allotted on rights basis of its WOS- NIL. 5. The draft Scheme of Amalgamation of Buli Chemicals India Private Limited - wholly owned subsidiary ("Transferor Company?) with Neogen Chemical Limited- the holding company (?Transferee Company?) and their respective shareholders ("Scheme"), based on the recommendation of the Audit Committee, under section 230 to 232 and other applicable provisions of the Companies Act, 2013 and rules framed thereunder. The Scheme inter alia provides for the amalgamation of the Transferor Company with the Transferee Company. The Transferor Company is the wholly owned subsidiary of the Transferee Company. The Scheme is subject to necessary statutory and regulatory approvals under the applicable laws, including approval of the jurisdictional Hon?ble National Company Law Tribunal. |
| 12-Mar-2024 | Neogen Chemicals submits analyst meet intimation | <div style="text-align: justify;">Pursuant to Regulation 30 of the Listing Regulations, Neogen Chemicals has informed that the management of Neogen Chemicals will be participating in the Analysts/Investors Group meeting on May 29, 2024. The discussion will be within the purview of Neogen Chemicals' business overview, financial performance and outlook. Further, this intimation is also uploaded on the company's website at https://neogenchem.com/investor-meet-presentation/</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE. </div><div style="text-align: justify;"><br></div> |
| 06-Jan-2024 | Neogen Chemicals informs about credit rating | <div style="text-align: justify;">Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulation), Neogen Chemicals has informed that based on ratings received from CRISIL Ratings, the Credit Rating of the Company for the debt instruments/ facilities of the Company are enclosed. This information is also being uploaded on the company's website at https://neogenchem.com/announcements/</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
| 03-Aug-2023 | Neogen Chemicals planning to raise funds | <p style="text-align: justify;">Neogen Chemicals is planning to raise funds by issue of equity shares and/or other equity linked securities, through permissible mode(s) including but not limited to a private placement, preferential issue, qualified institutions placement, foreign currency convertible bonds, further public offer, etc., or any combination thereof, subject to shareholders' approval and such regulatory and other approvals as may be required. The Board of Directors of the Company in its meeting scheduled to be held on August 5, 2023, inter alia, may also consider, evaluate and approve the same. </p><p style="text-align: justify;">Neogen Chemicals is one of India's leading manufacturers of bromine-based, and lithium-based, specialty chemicals.</p><div style="text-align: justify;"><br></div> |
